Japan’s top drugmaker on Friday reported an annual loss

Japan’s top drugmaker on Friday reported an annual loss for the first time in its history after agreeing to pay $2.4 billion to settle U.S. lawsuits over cancer claims regarding its Actos diabetes drug.

Japan Today

HINTS
drugmaker reported an annual loss

agreeing to pay $2.4 billion to settle lawsuits over claims regarding its drug

『英会話レッスン』のご案内

『英会話レッスン』のご案内です♪

【福岡西区 糸島 姪浜 英会話カフェ】ビーチを見ながら、心地良い空間で、リラックスして英語を話せますよ♪